570 related articles for article (PubMed ID: 31658991)
1. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
[TBL] [Abstract][Full Text] [Related]
2. Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates.
Schmitz R; Fitch ZW; Manook M; Schroder PM; Choi AY; Olaso D; Yoon J; Bae Y; Shaw BI; Song M; Kuchibhatla M; Farris AB; Kirk A; Kwun J; Knechtle SJ
Kidney360; 2022 Dec; 3(12):2116-2130. PubMed ID: 36591367
[TBL] [Abstract][Full Text] [Related]
3. Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients.
Burghuber CK; Manook M; Ezekian B; Gibby AC; Leopardi FV; Song M; Jenks J; Saccoccio F; Permar S; Farris AB; Iwakoshi NN; Kwun J; Knechtle SJ
Am J Transplant; 2019 Mar; 19(3):724-736. PubMed ID: 30102844
[TBL] [Abstract][Full Text] [Related]
4. Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model.
Schroder PM; Schmitz R; Fitch ZW; Ezekian B; Yoon J; Choi AY; Manook M; Barbas A; Leopardi F; Song M; Farris AB; Collins B; Kwun J; Knechtle SJ
Kidney Int; 2021 Jan; 99(1):161-172. PubMed ID: 32898569
[TBL] [Abstract][Full Text] [Related]
5. Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.
Kim EJ; Kwun J; Gibby AC; Hong JJ; Farris AB; Iwakoshi NN; Villinger F; Kirk AD; Knechtle SJ
Am J Transplant; 2014 Jan; 14(1):59-69. PubMed ID: 24354871
[TBL] [Abstract][Full Text] [Related]
6. Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant.
Manook M; Olaso D; Anwar IJ; Yoon J; Delaura I; Bae Y; Moris D; Shaw B; Song M; Farris AB; Jackson A; Kwun J; Knechtle S
Sci Adv; 2023 May; 9(20):eadg1448. PubMed ID: 37205758
[TBL] [Abstract][Full Text] [Related]
7. Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model.
Anwar IJ; Ezekian B; DeLaura I; Manook M; Schroder P; Yoon J; Curfman V; Branum E; Messina J; Harnois M; Permar SR; Farris AB; Kwun J; Knechtle SJ
Am J Transplant; 2022 Dec; 22 Suppl 4(Suppl 4):1-11. PubMed ID: 36239200
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.
Burghuber CK; Kwun J; Page EJ; Manook M; Gibby AC; Leopardi FV; Song M; Farris AB; Hong JJ; Villinger F; Adams AB; Iwakoshi NN; Knechtle SJ
Am J Transplant; 2016 Jun; 16(6):1726-38. PubMed ID: 26705099
[TBL] [Abstract][Full Text] [Related]
9. A prospective, iterative, adaptive trial of carfilzomib-based desensitization.
Tremblay S; Driscoll JJ; Rike-Shields A; Hildeman DA; Alloway RR; Girnita AL; Brailey PA; Woodle ES
Am J Transplant; 2020 Feb; 20(2):411-421. PubMed ID: 31550069
[TBL] [Abstract][Full Text] [Related]
10. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization.
Choi AY; Manook M; Olaso D; Ezekian B; Park J; Freischlag K; Jackson A; Knechtle S; Kwun J
Front Immunol; 2021; 12():694763. PubMed ID: 34177960
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.
Kwun J; Matignon M; Manook M; Guendouz S; Audard V; Kheav D; Poullot E; Gautreau C; Ezekian B; Bodez D; Damy T; Faivre L; Menouche D; Yoon J; Park J; Belhadj K; Chen D; Bilewski AM; Yi JS; Collins B; Stegall M; Farris AB; Knechtle S; Grimbert P
J Am Soc Nephrol; 2019 Jul; 30(7):1206-1219. PubMed ID: 31227636
[TBL] [Abstract][Full Text] [Related]
12. Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition.
Alishetti S; Farr M; Jennings D; Serban G; Uriel N; Sayer G; Vasilescu R; Restaino S; Chong AS; Habal MV
Am J Transplant; 2020 Dec; 20(12):3620-3630. PubMed ID: 32506824
[TBL] [Abstract][Full Text] [Related]
13. Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates.
Kwun J; Burghuber C; Manook M; Ezekian B; Park J; Yoon J; Yi JS; Iwakoshi N; Gibby A; Hong JJ; Farris AB; Kirk AD; Knechtle SJ
Blood Adv; 2017 Nov; 1(24):2115-2119. PubMed ID: 29296858
[TBL] [Abstract][Full Text] [Related]
14. Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.
Leibler C; Thiolat A; Elsner RA; El Karoui K; Samson C; Grimbert P
Kidney Int; 2019 Apr; 95(4):774-786. PubMed ID: 30711200
[TBL] [Abstract][Full Text] [Related]
15. Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.
Mulvihill MS; Samy KP; Gao QA; Schmitz R; Davis RP; Ezekian B; Leopardi F; Song M; How T; Williams K; Barbas A; Collins B; Kirk AD
Am J Transplant; 2019 Aug; 19(8):2350-2357. PubMed ID: 30891931
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose.
Steines L; Poth H; Schuster A; Amann K; Banas B; Bergler T
Front Immunol; 2021; 12():657894. PubMed ID: 34135891
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates.
Fida N; Eagar TN; Yun AN; Rogers AW; Nguyen DT; Graviss EA; Ishaq F; DiPaola NR; Kim J; Janardhana G; Kassi M; Yousefzai R; Suarez EE; Bhimaraj A; Krisl JC; Guha A
Clin Transplant; 2024 Feb; 38(2):e15249. PubMed ID: 38369810
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation.
Guthoff M; Schmid-Horch B; Weisel KC; Häring HU; Königsrainer A; Heyne N
Transpl Immunol; 2012 Jun; 26(4):171-5. PubMed ID: 22326708
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of alloantibody production in sensitized renal allograft recipients.
Stegall MD; Dean PG; Gloor J
Am J Transplant; 2009 May; 9(5):998-1005. PubMed ID: 19422329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
